Completed
Lung Health Study II
Led by University of Minnesota · Updated on 2019-11-01
1116
Participants Needed
N/A
Research Sites
295 weeks
Total Duration
On this page
Sponsors
U
University of Minnesota
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
To determine if participants with chronic obstructive pulmonary disease, who were assigned to inhaled corticosteroids had a lower rate of decline in lung function and lower incidence of respiratory morbidity compared to participants assigned to placebo.
CONDITIONS
Official Title
Lung Health Study II
Who Can Participate
Eligibility Criteria
You may qualify if you...
Inclusion:
- Previously participated in or screened for the Lung Health Study I
- Ages 40 to 69
- Forced expiratory volume at one second (FEV1)/forced vital capacity(FVC) < 70 percent
- Forced expiratory volume at one second (FEV1) 30 to 90 percent predicted.
Exclusions:
- Cancer
- Recent myocardial infarction
- Alcoholism
- Heart Failure
- Insulin-dependent diabetes mellitus
- Neuropsychiatric disorders
- Used bronchodilators or oral or inhaled corticosteroids in previous year
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here